Recent News

• 04.14.2025 - Voting Rights and Shares Capital of the Company
• 04.14.2025 - Voting Rights and Shares Capital of the Company
• 04.03.2025 - Full Year 2024 Financial Results
• 04.03.2025 - Full Year 2024 Financial Results
• 04.03.2025 - David Dai
• 04.03.2025 - David Dai
• 04.02.2025 - NANOBIOTIX Provides Business Update and Reports Full Year 2024 Financial Results
• 04.02.2025 - NANOBIOTIX Provides Business Update and Reports Full Year 2024 Financial Results
• 03.31.2025 - NANOBIOTIX to Announce Fourth Quarter and Full Year 2024 Operational and Financial Update on April 2, 2025
• 03.31.2025 - NANOBIOTIX to Announce Fourth Quarter and Full Year 2024 Operational and Financial Update on April 2, 2025

Recent Filings

• 04.14.2025 - EX-99.1 EX-99.1
• 04.14.2025 - EX-99.1 EX-99.1
• 04.14.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.14.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.10.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.10.2025 - EX-99.1 EX-99.1
• 04.02.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.02.2025 - EX-99.1 EX-99.1
• 04.02.2025 - 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
• 03.31.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]